| It's not uncommon for companies who launch commercial drug products in the pre-filled syringe format to do so after initially using other product formats such as vials for the development and clinical trial phases. Switch-overs need careful and strategic consideration because doing so requires investment in the new format but also offers critical patient benefits and improved stakeholder outcomes. Download this whitepaper to learn: Critical patient benefits and improved outcomes of prefilled syringes How to select the most appropriate prefilled syringe How to bridge vials with prefilled syringes | 